Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT)

ObjectiveTo determine the minimal clinically important difference (MCID) for the health-utility measures EuroQol-5 dimensions (EQ-5D) and Quality of Well Being Self-Administered (QWB-SA) Scale in PTSD patients.Research design and methodsTwo hundred patients aged 18 to 65 years with PTSD enrolled in a doubly randomized preference trial (DRPT) examining the treatment and treatment-preference effects between cognitive behavioral therapy and pharmacotherapy with sertraline and completed the EQ-5D and QWB-SA at baseline and 10-week post-treatment. The anchor-based methods utilized a Clinical Global Impression-Improvement (CGI-I) and Clinical Global Impression-Severity. We regressed the changes in EQ-5D and QWB-SA scores on changes in the anchors using ordinary least squares regression. The slopes (beta coefficients) were the rates of change in the anchors as functions of change in EQ-5D and QWB, which represent our estimates of MCID. In addition, we performed receiver operating characteristic (ROC) curve analysis to examine the relationship between the changes in EQ-5D and QWB-SA scores and treatment-response status. The MCIDs were estimated from the ROC curve where they best discriminate between treatment responders and non-responders. The distribution-based methods used small to moderate effect size in terms of 0.2 and 0.5 of standard deviation of the pre-treatment EQ-5D and QWB-SA scores.ResultsThe anchor-based methods estimated the MCID ranges of 0.05 to 0.08 for the EQ-5D and 0.03 to 0.05 for the QWB. The MCID ranges were higher with the distribution-based methods, ranging from 0.04 to 0.10 for the EQ-5D and 0.02 to 0.05 for the QWB-SA.ConclusionsThe established MCID ranges of EQ-5D and QWB-SA can be a useful tool in assessing meaningful changes in patient’s quality of life for researchers and clinicians, and assisting health-policy makers to make informing decision in mental health treatment.Clinical trial registrationClinicaltrials.gov; Identifier: NCT00127673.

[1]  John E. Brazier,et al.  Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D , 2005, Quality of Life Research.

[2]  M. Kosinski,et al.  Evaluation of the meaningfulness of health‐related quality of life improvements as assessed by the SF‐36 and the EQ‐5D VAS in patients with active Crohn’s disease , 2009, Alimentary pharmacology & therapeutics.

[3]  T. Tanielian,et al.  Invisible Wounds of War Psychological and Cognitive Injuries, Their Consequences, and Services to Assist Recovery , 2022 .

[4]  Edna B. Foa,et al.  The Validation of a Self-Report Measure of Posttraumatic Stress Disorder , 1997 .

[5]  N. Jacobson,et al.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. , 1991, Journal of consulting and clinical psychology.

[6]  Ross D Crosby,et al.  Defining clinically meaningful change in health-related quality of life. , 2003, Journal of clinical epidemiology.

[7]  Robert M. Kaplan,et al.  The quality of well-being scale: Comparison of the interviewer-administered version with a self-administered questionnaire , 1997 .

[8]  Tracie O. Afifi,et al.  Physical and Mental Comorbidity, Disability, and Suicidal Behavior Associated With Posttraumatic Stress Disorder in a Large Community Sample , 2007, Psychosomatic medicine.

[9]  Terri Tanielian,et al.  Invisible Wounds of War. Psychological and Cognitive Injuries, Their Consequences, and Services to Assist Recovery , 2008 .

[10]  J. Pyne,et al.  Quality-Adjusted Health Status in Veterans With Posttraumatic Stress Disorder , 2006, The Journal of nervous and mental disease.

[11]  R. Hays,et al.  Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. , 2008, Journal of clinical epidemiology.

[12]  C. Engel,et al.  Preference-weighted health status of PTSD among veterans: an outcome for cost-effectiveness analysis using clinical data. , 2009, Psychiatric services.

[13]  Jeffrey A. Johnson,et al.  Using Instrument-Defined Health State Transitions to Estimate Minimally Important Differences for Four Preference-Based Health-Related Quality of Life Instruments , 2010, Medical care.

[14]  E. Blanchard,et al.  Psychometric properties of the PTSD Checklist (PCL). , 1996, Behaviour research and therapy.

[15]  R. Kaplan.  The Minimally Clinically Important Difference in Generic Utility-Based Measures , 2005, COPD.

[16]  R. Kessler,et al.  The economic burden of anxiety disorders in the 1990s. , 1999, The Journal of clinical psychiatry.

[17]  Frank de Charro,et al.  The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective , 2003, Springer Netherlands.

[18]  R. Kessler,et al.  Posttraumatic stress disorder in the National Comorbidity Survey. , 1995, Archives of general psychiatry.

[19]  R. Hays,et al.  Responsiveness and minimal important differences for patient reported outcomes , 2006, Health and quality of life outcomes.

[20]  M. Neary,et al.  Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer , 2010, Health and Quality of Life Outcomes.

[21]  A. Jette,et al.  A Longitudinal Comparison of 5 Preference-Weighted Health State Classification Systems in Persons with Intervertebral Disk Herniation , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[22]  L. Zoellner,et al.  Predictors of health-related quality-of-life utilities among persons with posttraumatic stress disorder. , 2011, Psychiatric services.

[23]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[24]  D. Charney,et al.  The development of a Clinician-Administered PTSD Scale , 1995, Journal of traumatic stress.

[25]  R A Deyo,et al.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. , 1991, Controlled clinical trials.

[26]  Paul Kind,et al.  Guidelines for value sets in economic and non-economic studies using EQ-5D , 2003 .

[27]  M. Ward,et al.  Identification of clinically important changes in health status using receiver operating characteristic curves. , 2000, Journal of clinical epidemiology.

[28]  C. Hoge,et al.  Combat duty in Iraq and Afghanistan, mental health problems and barriers to care. , 2004, U.S. Army Medical Department journal.

[29]  Miranda Olff,et al.  Posttraumatic stress symptoms and health-related quality of life: a two year follow up study of injury treated at the emergency department , 2012, BMC Psychiatry.

[30]  G. Guyatt,et al.  Using the entire cohort in the receiver operating characteristic analysis maximizes precision of the minimal important difference. , 2009, Journal of clinical epidemiology.

[31]  R. Kaplan,et al.  Minimal clinically important difference for the UCSD Shortness of Breath Questionnaire. , 2005, Journal of cardiopulmonary rehabilitation.

[32]  R. Hays,et al.  Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease , 2003, Health and quality of life outcomes.

[33]  Barbara O. Rothbaum,et al.  Reliability and validity of a brief instrument for assessing post‐traumatic stress disorder , 1993 .

[34]  M V Mendlowicz,et al.  Quality of life in individuals with anxiety disorders. , 2000, The American journal of psychiatry.

[35]  P. Asbell,et al.  Minimal clinically important difference for the ocular surface disease index. , 2010, Archives of ophthalmology.

[36]  C. Marmar,et al.  Posttraumatic stress disorder and health-related quality of life in patients with coronary heart disease: findings from the Heart and Soul Study. , 2009, Archives of general psychiatry.

[37]  N. Greenberg.  Invisible Wounds of War: Psychological and Cognitive Injuries, Their Consequences and Services to Assist Recovery , 2009 .

[38]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[39]  Stephen Joel Coons,et al.  US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.

[40]  N. Jacobson,et al.  Methods for defining and determining the clinical significance of treatment effects: description, application, and alternatives. , 1999, Journal of consulting and clinical psychology.